For PSA, a previous observational study on prostate cancer screening in low- and middle-income countries showed that the prevalence of prostate cancer screening was higher among people with a higher wealth index compared to those with a lower wealth index in countries such as Namibia, Honduras, and the Dominican Republic [37]. The gene discussed is KLK3; the disease is prostate carcinoma.